Acute stroke therapy at the crossroads

JAMA

Volumn 306, Issue 18, 2011, Pages 2026-2028

  Broderick, Joseph P ^a   Meyers, Philip M ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; EDITORIAL; HEALTH CARE COST; HUMAN; ONSET AGE; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; REIMBURSEMENT; TREATMENT RESPONSE;

EID: 80755169821     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1622     Document Type: Editorial

References (18)

1. Lees KR, Bluhmki E, von Kummer R, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9727):1695-1703.
2. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke: NINDS rt-PA Stroke Study Group. Neurology. 1998;50(4):883-890. (Pubitemid 28212810)
3. Meyers PM, Schumacher HC, Connolly ES Jr, Heyer EJ, Gray WA, Higashida RT. Current status of endovascular stroke treatment. Circulation. 2011;123(22):2591-2601.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282(21):2003-2011.
5. Powers WP, Clarke WR, Grubb RL, Videen TO, Adams HP, Derdeyn CP; Carotid Occlusion Surgery Study (COSS) Investigators. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA. 2011;306(18):1983-1992.
6. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med. 1985;313(19):1191-1200.
7. Mayer SA, Brun NC, Begtrup K, et al. FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127-2137. (Pubitemid 351679599)
8. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial artery stenosis. N Engl J Med. 2011;365(11):993-1003.
9. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007;38(7):2127-2135.
10. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA; IMS I and II Investigators. Good clinical outcomes after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73(13):1066- 1072.
11. Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40(8):2761-2768.
12. Mazighi M, Serfaty JM, Labreuche J, et al.; RECANALISE investigators. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol. 2009;8(9):802-809.
13. Abou-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke. 2010;41(6):1175-1179.
14. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42(7):1952-1955.
15. Khatri P, Adeoye O, Kleindorfer DO. US rates of mechanical embolectomy for acute ischemic stroke treatment are increasing [abstract]. Stroke. 2010;41:e361. doi:10.1161/01.str.0000366115.56266.0a.
16. Weinstein MC, Skinner JA. Comparative effectiveness and health care spending: implications for reform. N Engl J Med. 2010;362(5):460-465.
17. Khatri P, Hill MD, Palesch YY, et al. Interventional Management of Stroke III Investigators. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008;3(2):130-137. (Pubitemid 351566847)
18. Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE). ClinicalTrials.gov Web site. http://clinicaltrials.gov/ct2/show/ study/NCT00389467. Accessed October 18, 2011.